ERAS

AS OF

Nov 13 closing price

Price

$2.54

Change

-$0.11 (-4.15%)

Capitalization

720.63M

125 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ERAS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ERAS is expected to report earnings to fall 2.18% to -10 cents per share on March 19

Q4'25

Est.

$-0.11

Q3'25

Missed

by $0.01

Q2'25

Est.

$-0.12

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.02

The last earnings report on November 12 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 1.30M shares outstanding, the current market capitalization sits at 720.63M.

View a ticker or compare two or three

Compare

ERAS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ERAS showed earnings on November 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ERAS

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3115 Merryfield Row

Phone

+1 858 465-6511

Employees

126

Web

https://www.erasca.com